The left panel shows the structure of the naturally occurring iminosugar DNJ, along with derivatives modified to increase antiviral efficacy. MON-DNJ, currently in clinical trial against dengue, is also referred to as UV4B. The right panel shows the structure of the naturally occurring iminosugar CAST along with the prodrug celgosivir which is in a phase II clinical trial against dengue.